Phase 1 Clinical Trial Commences
Perth, Oct 27, 2015 AEST (ABN Newswire) - MMJ PhytoTech Limited's (
ASX:MMJ) Management and Board are pleased to announce the commencement of the Phase 1 Clinical Trials being undertaken in Israel.
A summary of the Phase 1 Clinical Trial was released to the market on July 6, 2015.
To view the July 6 2015 release, please visit:
http://www.abnnewswire.net/lnk/0C5ZL1N7
About MMJ Group Holdings Ltd
MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: https://www.mmjphytotech.com.au/investors/
| ||
|
